|GRANTWAY
EN

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Centers for Disease Control and Prevention - ERA

Share
Favorite
Feedback
Summary
-
19 December 2023
-
$7,500,000
8
For profit
Individuals
Not for profit (incl. NGOs)
Public sector
R&D and Higher Education
-
Health, Justice and Social Welfare
Research, Development and Innovation Natural Sciences
Overview

The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will further the understanding of potential risk factors for Amyotrophic Lateral Sclerosis (ALS), while supporting the National ALS Registry's mission. The National ALS Registry's goals are to estimate the number of new ALS cases each year, estimate the number of people who have ALS at a specific point in time, better understand who gets ALS, and identify what contributing factors, including environmental, may affect ALS. CDC/ATSDR is seeking investigator-initiated research that will identify and evaluate risk factors contributing to ALS, with preferred focus in this Notice of Funding Opportunity on factors related to military service, contact sports, traumatic brain injury, neuroinflammation, environmental exposures, and infectious agents. Research proposals on preferred topics can be funded under one of two funding options, Funding Option A or Funding Option B.Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base foundation base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature.For Option A and B applicants may elect to use data from the National ALS Registry. Note, this is not compulsory and will not preclude the applicant from consideration.

Eligibility

See Section III. Eligibility Information.

Learn more or apply
All information about this funding has been collected from and belongs to the funding organization
02 August 2023